Bieżący numer
Archiwum
Artykuły zaakceptowane
O czasopiśmie
Rada naukowa
Bazy indeksacyjne
Kontakt
Zasady publikacji prac
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
3/2020
vol. 95 streszczenie artykułu:
Artykuł oryginalny
The role of serum cytokeratin 18 and platelet count as non-invasive markers in the diagnosis of nonalcoholic fatty liver disease in children with type 1 diabetes mellitus
Nagwa A. Ismail
1
,
Abeer M. N. E. Abd ElBaky
1
,
Mona H. Ibrahim
2
,
Wafaa Mohamed Ezzat
3
,
Yasser A. Elhosary
3
,
Eman A. Mostafa
1
,
Hoda H. Ahmed
1
,
Inas Abdel Rasheed
2
Pediatr Pol 2020; 95 (3): 141–148
Data publikacji online: 2020/10/30
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic hepatopathy in children and adults. Aim of the study To evaluate the role of cytokeratin 18 (CK-18) and platelet count as non-invasive markers in the diagnosis of nonalcoholic fatty liver disease in children with type 1 diabetes mellitus (T1DM). Material and methods The study included 71 T1DM patients with age range 6–18 years old and 48 healthy age- and sex-matched volunteers. The T1DM patients were divided into NAFLD(+) (n = 12) and NAFLD(–) (n = 40) groups. Blood samples were collected for assessment of complete blood count, complete lipid profile, glycosylated haemoglobin, liver enzymes, and serum CK-18. Ultrasonography distinctively quantifies visceral fat and subcutaneous fat, ultrasound evaluation of hepatic steatosis, and liver size. Acoustic radiation force impulse elastography was used to evaluate liver fibrosis. Results The mean serum cholesterol, triglyceride, and LDL-cholesterol were statistically significantly higher in cases with NAFLD compared to cases without NAFLD and controls (p = 0.033, p = 0.001, p = 0.023, respectively). Comparing with the controls, cases exhibited significantly higher values for platelets count (p < 0.005). Regarding the mean level of serum CK-18, it was 168.88 ±96.462 mIU/ml in patients without NAFLD vs. 173.29 ±101.95 mIU/ml in patients with NAFLD and 140.75 ±79.97 mIU/ml in controls. Interestingly, the observed positive correlation between serum CK-18 and platelets counts in diabetic patients was statistically significant (r = 0.230, p = 0.046). Platelets count and visceral fat thickness were statistically significantly predictors of NAFLD. Significantly higher serum CK-18 in cases with NAFLD and liver fibrosis compared with those without liver fibrosis evaluated by acoustic radiation force impulse elastography. Conclusions CK-18 and platelet count may be useful markers for predicting liver fibrosis and help in the follow-up regimen of NAFLD in cases with T1DM. słowa kluczowe:
cytokeratin 18, platelets count, nonalcoholic fatty liver disease, liver fibrosis, type1 diabetes mellitus |